- Home
- IMMP vs PANL Comparison
IMMP vs PANL Comparison
Compare IMMP & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- PANL
- Stock Information
- Founded
- IMMP 1987
- PANL 1996
- Country
- IMMP Australia
- PANL United States
- Employees
- IMMP N/A
- PANL N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- PANL Marine Transportation
- Sector
- IMMP Health Care
- PANL Consumer Discretionary
- Exchange
- IMMP Nasdaq
- PANL Nasdaq
- Market Cap
- IMMP 304.0M
- PANL 332.6M
- IPO Year
- IMMP N/A
- PANL N/A
- Fundamental
- Price
- IMMP $1.83
- PANL $5.55
- Analyst Decision
- IMMP Buy
- PANL Strong Buy
- Analyst Count
- IMMP 2
- PANL 1
- Target Price
- IMMP $8.50
- PANL N/A
- AVG Volume (30 Days)
- IMMP 82.5K
- PANL 227.2K
- Earning Date
- IMMP 03-25-2025
- PANL 03-13-2025
- Dividend Yield
- IMMP N/A
- PANL 7.37%
- EPS Growth
- IMMP N/A
- PANL 8.62
- EPS
- IMMP N/A
- PANL 0.63
- Revenue
- IMMP $3,019,249.00
- PANL $536,536,246.00
- Revenue This Year
- IMMP N/A
- PANL $4.27
- Revenue Next Year
- IMMP $20.28
- PANL $17.15
- P/E Ratio
- IMMP N/A
- PANL $8.62
- Revenue Growth
- IMMP 24.11
- PANL 7.46
- 52 Week Low
- IMMP $1.65
- PANL $4.69
- 52 Week High
- IMMP $3.34
- PANL $8.32
- Technical
- Relative Strength Index (RSI)
- IMMP 41.69
- PANL 60.29
- Support Level
- IMMP $1.65
- PANL $4.69
- Resistance Level
- IMMP $1.88
- PANL $5.07
- Average True Range (ATR)
- IMMP 0.10
- PANL 0.17
- MACD
- IMMP -0.01
- PANL 0.02
- Stochastic Oscillator
- IMMP 41.94
- PANL 82.22
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.